You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 康哲藥業漲逾5% 績後獲CEO、COO增持
格隆匯 04-08 11:05
格隆匯4月8日丨康哲藥業(0867.HK)現報9.3港元,漲5.08%,暫成交2882萬港元,最新總市值229億港元。根據聯交所最新權益披露資料顯示,康哲藥業於4月1日獲主席兼CEO林剛在場內以每股均價7.8849港元增持300萬股,涉資2365.47萬港元。增持後,林剛持股比例由44.64%升至44.76%。同日,公司亦獲執行董事、副總裁兼首席運營官陳洪兵在場內以每股均價7.8965港元增持80萬股,涉資631.72萬港元。增持後,陳洪兵持股比例由2.63%升至2.66%。此前,康哲藥業於3月31日晚間公佈,2019年度,公司營業額增長11.8%至60.74億元(人民幣,下同),若將“兩票制”收入還原則營業額增長12.4%至68.97億元;正常化年度溢利增長23.4%至22.77億元;擬派末期股息每股0.1271元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account